Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Emma B. Hodcroft, Moira Zuber, Sarah Nadeau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
Science (2021) Vol. 372, Iss. 6538
Open Access | Times Cited: 2450
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 936
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Erik Volz, Swapnil Mishra, Meera Chand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 649
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
Roy M. Anderson, Carolin Vegvari, James E. Truscott, et al.
The Lancet (2020) Vol. 396, Iss. 10263, pp. 1614-1616
Open Access | Times Cited: 551
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 515
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li, Jianhui Nie, Jiajing Wu, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2362-2371.e9
Open Access | Times Cited: 381
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 377
The emergence, genomic diversity and global spread of SARS-CoV-2
Juan Li, Shengjie Lai, George F. Gao, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 408-418
Open Access | Times Cited: 344
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain
Simona Iftimie, Ana F. López‐Azcona, Immaculada Vallverdú, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248029-e0248029
Open Access | Times Cited: 255
Ongoing global and regional adaptive evolution of SARS-CoV-2
Nash D. Rochman, Yuri I. Wolf, Guilhem Faure, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 29
Open Access | Times Cited: 242
Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence
Moritz U. G. Kraemer, Verity Hill, Christopher Ruis, et al.
Science (2021) Vol. 373, Iss. 6557, pp. 889-895
Open Access | Times Cited: 202
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1137-1150.e6
Open Access | Times Cited: 188
SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
Swapnil B. Kadam, Geetika S. Sukhramani, Pratibha Bishnoi, et al.
Journal of Basic Microbiology (2021) Vol. 61, Iss. 3, pp. 180-202
Open Access | Times Cited: 170
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil
Carolina Moreira Voloch, Ronaldo da Silva Francisco, Luiz Gonzaga Paula de Almeida, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 153
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003656-e1003656
Open Access | Times Cited: 140
Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677
Emma B. Hodcroft, Daryl Domman, Daniel J. Snyder, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 130
One Year of SARS-CoV-2: How Much Has the Virus Changed?
Santiago Vilar, Daniel G. Isom
Biology (2021) Vol. 10, Iss. 2, pp. 91-91
Open Access | Times Cited: 114
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Takuya Tada, Belinda M. Dcosta, Marie Samanovic-Golden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 114
Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
Katarina M. Braun, Gage K. Moreno, Peter Halfmann, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 2, pp. e1009373-e1009373
Open Access | Times Cited: 112
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 392-392
Open Access | Times Cited: 105
Page 1 - Next Page

Scroll to top